Endothelin-1 as a protective factor against beta-adrenergic agonist-induced apoptosis in cardiac myocytes

Journal of the American College of Cardiology

Volumn 36, Issue 4, 2000, Pages 1411-1418

  Araki, Makoto ^a   Hasegawa, Koji ^a   Iwai Kanai, Eri ^a   Fujita, Masatoshi ^a   Sawamura, Tatsuya ^b   Kakita, Tsuyoshi ^a   Wada, Hiromichi ^a   Morimoto, Tatsuya ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 8 BROMO CYCLIC AMP; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ENDOTHELIN 1; ISOPRENALINE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; RAPAMYCIN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BETA ADRENERGIC STIMULATION; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DRUG ANTAGONISM; HEART FAILURE; HEART MUSCLE CELL; HEART PROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ANIMAL; ANIMALS, NEWBORN; ANTIBIOTICS, MACROLIDE; APOPTOSIS; AZEPINES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; COMPARATIVE STUDY; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENDOTHELIN-1; ENZYME INHIBITORS; FLAVONES; HEART; INDOLES; ISOPROTERENOL; MYOCARDIUM; OLIGOPEPTIDES; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; SIROLIMUS; SUPPORT, NON-U.S. GOV'T;

EID: 0033810103     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00822-6     Document Type: Article

References (52)

1. Apoptosis, a basic biological phenomenon with wide-ranging implications in tissue kinetics
2. Programmed cell death in animal development
3. Apoptosis by death factor
4. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
5. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs
6. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure
7. Apoptosis in pressure overload-induced heart hypertrophy in the rat
8. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat
9. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
10. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group
11. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway
12. α- and β-Adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes
13. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
14. Endothelin in human congestive heart failure
15. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
16. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats
17. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: A paracrine mechanism for myocardial cell hypertrophy
18. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes
19. Cloning and expression of a cDNA encoding an endothelin receptor
20. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
21. Endothelin attenuates apoptosis in human smooth muscle cells
22. Endothelin-1 is a potent survival factor for c-myc-dependent apoptosis
23. 1-adrenergic-stimulated hypertrophy in cultured neonatal rat cardiac myocytes
24. Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells
25. Pharmacological profile of FR139317, a novel potent endothelin ET(A) receptor antagonist
26. Clearance of circulating endothelin-1 by ET(B) receptors in rats
27. 11,15]-endothelin-1(8-21), IRL1620, for the ET(B) receptor
28. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle
29. Inhibition of the cardiac protein kinase A-dependent chloride conductance by endothelin-1
30. A synthetic inhibitor of the mitogen-activated protein kinase cascade
31. Inhibition of MAP kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
32. Cardiotrophin 1 (CT-1) inhibition of cardiac myocytes apoptosis via a mitogen-activated protein kinase-dependent pathway
33. Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70(S6K) activity
34. Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase
35. Phosphatidyllinositol 3-kinase activation is required for insulin stimulation of pp70 S6-kinase, DNA synthesis, and glucose transporter translocation
36. PDGF-and insulin-dependent pp70 S6K activation mediated by phosphatidylinositol-3-OH kinase
37. Activation of pp70/85 S6 kinase and inhibited by cyclic AMP
38. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases
39. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase
40. Rapamycin selectively inhibits interleukin-2 activation of p70·S6 kinase
41. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homologue required for G1 progression
42. A mammalian protein targeted G1-arresting rapamycin-receptor complex
43. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs
44. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin
45. Immunophilins and the nervous system
46. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro: Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy
47. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin
48. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy
49. Endothelins stimulate mitogen-activated protein kinase cascade through either ETA or ETB
50. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelin A: The role of a wortmannin-sensitive signaling pathway
51. Insulin-like growth factor-1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways
52. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress